A Study to Compare the Efficacy and Safety of Luspatercept (ACE-536) Versus Epoetin Alfa for the Treatment of Anemia Due to IPSS-R Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Participants Who Require Red Blood Cell Transfusions and Are ESA Naïve
This research is looking at two different medicines, luspatercept and epoetin alfa, to treat a blood condition called myelodysplastic syndromes (MDS). People with MDS often have low red blood cell counts (anemia) and need regular blood transfusions. The main goal of this study is to find out if luspatercept is better than epoetin alfa at helping people become transfusion-independent, meaning they no longer need regular blood transfusions, and if it can also increase their red blood cell levels. The study focuses on people with specific types of MDS risk who haven't tried similar treatments before.
एक नजर में
परिणाम
इस अध्ययन के परिणाम
प्रकाशित जून 2024इस अध्ययन के परिणाम प्रकाशित कर दिए गए हैं।.
यह अध्ययन किस बारे में है?
You're reading about a research study for people with a blood condition called myelodysplastic syndromes, or MDS. MDS affects your bone marrow, which is the soft, spongy tissue inside your bones where new blood cells are made. In MDS, the bone marrow doesn't produce enough healthy blood cells, especially red blood cells. When you don't have enough healthy red blood cells, you can develop a condition called anemia, which can make you feel very tired and weak, and you might need regular blood transfusions.
This study is comparing two different medicines: luspatercept (sometimes called ACE-536) and epoetin alfa. Epoetin alfa is a common treatment that helps your body make more red blood cells. Luspatercept is a newer medicine, and researchers want to see if it works better than epoetin alfa. The main aim is to see if these medicines can help people with MDS stop needing blood transfusions for at least 12 weeks, and also increase their red blood cell count.
This is a 'Phase 3' study, which means it's one of the final steps in testing a new medicine to make sure it's both safe and effective before it can be widely used. Taking part in a study like this helps doctors learn more about the best ways to treat MDS, which can benefit many people in the future.
मुख्य निष्कर्ष
- This study compares luspatercept and epoetin alfa for MDS.
- The main goal is to reduce the need for blood transfusions.
- It's a Phase 3 study, meaning it's a final step in testing a new medicine.
- You will receive regular check-ups and blood tests if you participate.
- Participation could help improve future treatments for MDS.
- You can stop participating at any time without affecting your care.
कौन पात्र हो सकता है?
To join this study, doctors will first check if you have myelodysplastic syndromes (MDS) and if your condition is considered 'very low', 'low', or 'intermediate' risk. This is based on specific criteria that doctors use to classify MDS. An important part of joining is that you must be needing regular red blood cell transfusions. Specifically, you would have received between two and six units of blood every eight weeks for at least two months before the study starts. You also shouldn't have tried treatments like epoetin alfa before.
There are also some reasons why you might not be able to join. For example, if your anemia is caused by other easily treatable things like a lack of iron or vitamins, or if you have certain other serious health problems. You also wouldn't be able to join if you have a known history of acute myeloid leukaemia (AML) or if your blood pressure is not well controlled even with medication. The medical team will check all these carefully with you.
क्या यह अध्ययन आपके लिए उपयुक्त हो सकता है?
यह देखने के लिए इन त्वरित प्रश्नों का उत्तर दें कि क्या आप पात्र हो सकते हैं। यह केवल एक मार्गदर्शिका है — अंतिम निर्णय शोध टीम द्वारा लिया जाता है।.
- I have been diagnosed with MDS.
- My MDS is classified as 'very low', 'low', or 'intermediate' risk.
- I currently need regular red blood cell transfusions (2-6 units every 8 weeks).
- I have not previously taken similar medications like epoetin alfa.
- I am generally well enough to participate in a study.
- My blood pressure is generally well-controlled.
भागीदारी में क्या शामिल है?
If you decide to take part, you'll be assigned to receive either luspatercept or epoetin alfa. Neither you nor your doctor will get to choose which medicine you receive, and often you won't know which one it is (this is called a 'blinded' study). You'll have regular visits to the clinic for medical check-ups, blood tests, and to receive your study medicine. These visits will help the doctors monitor how you're doing, check your blood counts, and look for any side effects. The total duration of your participation in the study will depend on how you respond to the treatment and the study's design, but it will involve ongoing assessments and follow-up care.
संभावित जोखिम और लाभ
Locations (226)
- Local Institution - 107सत्यापित पोस्टकोडबर्कले, संयुक्त राज्य अमेरिका
- Local Institution - 115सत्यापित पोस्टकोडसैन डिएगो, संयुक्त राज्य अमेरिका
- Local Institution - 101सत्यापित पोस्टकोडव्हिटियर, संयुक्त राज्य अमेरिका
- Local Institution - 104सत्यापित पोस्टकोडन्यू हेवन, संयुक्त राज्य अमेरिका
- Local Institution - 136सत्यापित पोस्टकोडवॉशिंगटन डी.सी., संयुक्त राज्य अमेरिका
- Local Institution - 119सत्यापित पोस्टकोडHudson, United States
- Local Institution - 120सत्यापित पोस्टकोडसेंट पीटर्सबर्ग, संयुक्त राज्य अमेरिका
- Local Institution - 122सत्यापित पोस्टकोडटल्लाहैसी, संयुक्त राज्य अमेरिका
- Local Institution - 108सत्यापित पोस्टकोडटाम्पा, संयुक्त राज्य अमेरिका
- Local Institution - 118सत्यापित पोस्टकोडवेस्ट पाम बीच, संयुक्त राज्य अमेरिका
- Local Institution - 102सत्यापित पोस्टकोडपडुका, संयुक्त राज्य अमेरिका
- Local Institution - 123सत्यापित पोस्टकोडबेथेस्डा, संयुक्त राज्य अमेरिका
सामान्य प्रश्न
What is MDS?
MDS (Myelodysplastic Syndromes) is a condition where your bone marrow doesn't make enough healthy blood cells, often leading to low red blood cell counts and anemia.
What does 'transfusion independence' mean?
It means you no longer need regular blood transfusions because your body is making enough red blood cells on its own, or with the help of medication.
Why can't I choose which medicine I get?
In studies like this, treatments are often given randomly, and sometimes neither you nor your doctor knows which medicine you are receiving. This helps ensure the study results are fair and unbiased.
अगर मुझे दुष्प्रभाव होते हैं तो क्या करें?
The study team will closely monitor you for any side effects and will provide care and advice. You should always tell them about any new or worsening symptoms.
क्या मैं किसी भी समय अध्ययन छोड़ सकता हूँ?
Yes, you have the right to withdraw from the study at any point, and this will not affect your future medical care.
और अधिक जानने के लिए कैसे पता करें
किसी अध्ययन में भाग लेने का निर्णय लेने से पहले हमेशा अपने जीपी या विशेषज्ञ से बात करें।.
चर्चा
समुदाय चर्चा
हमारे फोरम द्वारा संचालित community.patient.info. कृपया सम्मानजनक रहें — यह चिकित्सा सलाह नहीं है।.